dpp 4 inhibitor and glp 1 receptor agonist combination Mechanism of action for GIP, GLP-1 analogues DPP4 inhibitors in Differences between GLP-1 receptor agonists

Some people experience mild digestive upset during or after treatment things like cramping, bloating, or nausea

Semaglutide and tirzepatide allow for albumin binding and resistance to DPP4 degradation, creating a significantly longer half-life (5 days for tirzepatide and 7 days for semaglutide) and thus a greater effect on receptors and downstream pathways in the central nervous, cardiovascular, digestive, and musculoskeletal systems as described below [37, 38]

If FMO3 enzyme production is compromised, or there is too much TMA for the amount of enzyme, then TMA will continue to circulate in the bloodstream until enough enzyme is produced

It has also been proposed to help by lowering stress and reversing maladaptive changes in brain neuronal networks involved in perpetuating tinnitus